Asset Details
Do you wish to reserve the book?
477 Survival analysis of endometrial cancer. our experience in las palmas de gran canaria
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
477 Survival analysis of endometrial cancer. our experience in las palmas de gran canaria
Do you wish to request the book?
477 Survival analysis of endometrial cancer. our experience in las palmas de gran canaria
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
477 Survival analysis of endometrial cancer. our experience in las palmas de gran canaria
2021
Overview
Introduction/Background*Self-evaluation and analysis of healthcare practice in a Gynecology Oncology unit represents an advance in the strategy to improve the quality of cancer care, in this case,endometrial cancer, allowing to obtain relevant data on the quality of care practice.MethodologyRetrospective descriptive study carried out in CHUIMI. We included patients diagnosed with endometrial cancer during the study period 2012-2016. We analyzed epidemiological variables, histological type, type of treatment, final FIGO stage and 5-year overall survival.Result(s)*A total of 498 patients were diagnosed with endometrial cancer during this period. Mean age of 64.3 years (range 29–89 years) and a mean BMI of 33.5. 60.2% of the patients were diagnosed in stage IA; 48.7% of which were grade 1 and 2. Type I (endometrioid and mucinous) accounted for 74.3% versus 25.7% type II. 40.8% of the patients were classified as low risk presenting a 5-year survival of 99%. Patients with intermediate risk represented 5.9% and had a 96% 5-year survival. Patients with intermediate-high risk (19.7%) had a 5-year survival of 88%. The patients included in the high-risk group (28.2%), had a 5-year survival of 62%, these differences were statistically significant.We analyzed survival according to the histological type, finding a 5-year overall survival rate of 91.9% in type I, while it was 60.8% fot type II, these differences were statistically significant.Conclusion*The data analyzed in our Gynecology Oncology Unit are similar to those exposed in the literature, there is an important difference in terms of 5-year survival between the low and high risk groups, 99% vs 62% respectively.
Publisher
BMJ Publishing Group Ltd,Elsevier Inc,Elsevier Limited
Subject
